Yangle Li

557 total citations
30 papers, 384 citations indexed

About

Yangle Li is a scholar working on Surgery, Molecular Biology and Cancer Research. According to data from OpenAlex, Yangle Li has authored 30 papers receiving a total of 384 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 12 papers in Molecular Biology and 10 papers in Cancer Research. Recurrent topics in Yangle Li's work include Bladder and Urothelial Cancer Treatments (8 papers), Cancer-related molecular mechanisms research (7 papers) and Genital Health and Disease (5 papers). Yangle Li is often cited by papers focused on Bladder and Urothelial Cancer Treatments (8 papers), Cancer-related molecular mechanisms research (7 papers) and Genital Health and Disease (5 papers). Yangle Li collaborates with scholars based in China. Yangle Li's co-authors include Xiheng Hu, Zhaohui Zhong, Xiaokun Zhao, Xiongbing Zu, Songchao Li, Yi Wang, Miao Mo, Jun Fu, Wei He and Shiyu Tong and has published in prestigious journals such as Journal of Clinical Oncology, The Journal of Urology and Life Sciences.

In The Last Decade

Yangle Li

29 papers receiving 380 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yangle Li China 13 214 165 117 82 44 30 384
Xiheng Hu China 14 250 1.2× 167 1.0× 140 1.2× 130 1.6× 80 1.8× 48 482
Bogdan Petruţ Romania 11 255 1.2× 230 1.4× 80 0.7× 106 1.3× 42 1.0× 41 431
Tomoya Fukawa Japan 11 164 0.8× 60 0.4× 116 1.0× 104 1.3× 78 1.8× 62 392
Xiong‐Lin Sun China 12 99 0.5× 68 0.4× 94 0.8× 119 1.5× 35 0.8× 28 303
Yun‐Zhi Lin China 13 130 0.6× 103 0.6× 77 0.7× 209 2.5× 61 1.4× 32 378
Qingcong Kong China 9 57 0.3× 83 0.5× 129 1.1× 71 0.9× 31 0.7× 19 328
Hai-Liang Zhang China 14 187 0.9× 103 0.6× 99 0.8× 249 3.0× 90 2.0× 18 451
Uğur Mungan Türkiye 11 107 0.5× 69 0.4× 159 1.4× 148 1.8× 67 1.5× 30 348
Nobuyoshi Takeuchi Japan 7 79 0.4× 135 0.8× 53 0.5× 69 0.8× 69 1.6× 25 322
Gui-Ming Zhang China 12 132 0.6× 118 0.7× 77 0.7× 157 1.9× 144 3.3× 21 361

Countries citing papers authored by Yangle Li

Since Specialization
Citations

This map shows the geographic impact of Yangle Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yangle Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yangle Li more than expected).

Fields of papers citing papers by Yangle Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yangle Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yangle Li. The network helps show where Yangle Li may publish in the future.

Co-authorship network of co-authors of Yangle Li

This figure shows the co-authorship network connecting the top 25 collaborators of Yangle Li. A scholar is included among the top collaborators of Yangle Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yangle Li. Yangle Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Ou, Zhenyu, Peihua Liu, Zhao Cheng, et al.. (2023). ATXN3 promotes prostate cancer progression by stabilizing YAP. Cell Communication and Signaling. 21(1). 152–152. 11 indexed citations
3.
Tong, Shiyu, et al.. (2022). Niban apoptosis regulator 1 promotes gemcitabine resistance by activating the focal adhesion kinase signaling pathway in bladder cancer. Journal of Cancer. 13(4). 1103–1118. 14 indexed citations
4.
Tong, Shiyu, Xiheng Hu, & Yangle Li. (2022). Serum IL-6 level is associated with clinical outcome of intravesical gemcitabine therapy in T1 non-muscle–invasive bladder cancer. Urologic Oncology Seminars and Original Investigations. 40(9). 412.e1–412.e8. 4 indexed citations
5.
Li, Yangle, et al.. (2021). Competing endogenous RNA network analysis reveals pivotal ceRNAs in bladder urothelial carcinoma. Translational Andrology and Urology. 10(2). 797–808. 4 indexed citations
6.
Wang, Zhi, Yichuan Zhang, Zhao Cheng, et al.. (2021). The miR-223-3p/MAP1B axis aggravates TGF-β-induced proliferation and migration of BPH-1 cells. Cellular Signalling. 84. 110004–110004. 21 indexed citations
7.
Li, Chao, Jiao Hu, Xiheng Hu, et al.. (2021). LncRNA SNHG9 is a prognostic biomarker and correlated with immune infiltrates in prostate cancer. Translational Andrology and Urology. 10(1). 215–226. 27 indexed citations
8.
Mo, Miao, Xiheng Hu, Wei He, et al.. (2021). Identification of key genes and microRNA regulatory network in development and progression of urothelial bladder carcinoma. Translational Andrology and Urology. 10(1). 438–447. 1 indexed citations
9.
Zhao, Cheng, et al.. (2020). MEST promotes bladder cancer cell proliferation, migration and invasion via STAT3/Twist-1-mediated EMT. Translational Cancer Research. 9(10). 6178–6188. 8 indexed citations
10.
Liu, Peihua, et al.. (2020). Silencing of miR-152 contributes to DNMT1-mediated CpG methylation of the PTEN promoter in bladder cancer. Life Sciences. 261. 118311–118311. 17 indexed citations
11.
Sun, Xi, Yi Cai, Xiheng Hu, et al.. (2020). Long noncoding RNA MAFG-AS1 facilitates bladder cancer tumorigenesis via regulation of miR-143-3p/SERPINE1 axis. Translational Cancer Research. 9(11). 7214–7226. 13 indexed citations
12.
Yi, Zhenglin, Renyu Liu, Jiao Hu, et al.. (2020). Clinicopathologic Features and Survival Outcomes for Primary Renal Neuroendocrine Neoplasms. Clinical Genitourinary Cancer. 19(2). 155–161. 8 indexed citations
13.
Hu, Xiheng, Mingfeng Chen, Wentao Liu, Yangle Li, & Jun Fu. (2019). Preoperative plasma IGFBP2 is associated with nodal metastasis in patients with penile squamous cell carcinoma. Urologic Oncology Seminars and Original Investigations. 37(7). 452–461. 13 indexed citations
14.
Zhang, Mengda, Lin Qi, Xiongbing Zu, et al.. (2019). ERα-mediated alterations in circ_0023642 and miR-490-5p signaling suppress bladder cancer invasion. Cell Death and Disease. 10(9). 635–635. 33 indexed citations
15.
Liu, Longfei, Lin Qi, Yangle Li, et al.. (2016). Retroperitoneoscopic Partial Nephrectomy for Moderately Complex Ventral Hilar Tumors: Surgical Technique and Trifecta Outcomes from a Single Institution in China. Journal of Laparoendoscopic & Advanced Surgical Techniques. 27(8). 812–817. 6 indexed citations
16.
Qi, Lin, Yuan Li, Yangle Li, et al.. (2014). Preservation of the saphenous vein during laparoendoscopic single‐site inguinal lymphadenectomy: comparison with the conventional laparoscopic technique. British Journal of Urology. 115(4). 613–618. 20 indexed citations
17.
Li, Yangle, Minfeng Chen, Xu Zhou, et al.. (2013). CXCR4 Expression in Bladder Transitional Cell Carcinoma and Its Relationship with Clinicopathological Features. Urologia Internationalis. 92(2). 157–163. 8 indexed citations
18.
Li, Songchao, et al.. (2012). microRNA-155 silencing inhibits proliferation and migration and induces apoptosis by upregulating BACH1 in renal cancer cells. Molecular Medicine Reports. 5(4). 949–954. 70 indexed citations
19.
Li, Yangle, Zhaohui Zhong, & Xiaokun Zhao. (2011). Primary Mature Teratoma Presenting as an Adrenal Tumor in a Child. Urology. 78(3). 689–691. 20 indexed citations
20.
Li, Yangle, Xiaokun Zhao, Zhaohui Zhong, et al.. (2011). Effects of YC-1 on Hypoxia-Inducible Factor 1 Alpha in Hypoxic Human Bladder Transitional Carcinoma Cell Line T24 Cells. Urologia Internationalis. 88(1). 95–101. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiheng Hu Breakdown of academic impact, for papers by Bogdan Petruţ Breakdown of academic impact, for papers by Tomoya Fukawa Breakdown of academic impact, for papers by Xiong‐Lin Sun Breakdown of academic impact, for papers by Yun‐Zhi Lin Breakdown of academic impact, for papers by Qingcong Kong Breakdown of academic impact, for papers by Hai-Liang Zhang Breakdown of academic impact, for papers by Uğur Mungan Breakdown of academic impact, for papers by Nobuyoshi Takeuchi Breakdown of academic impact, for papers by Gui-Ming Zhang
Rankless by CCL
2026